TP53 and breast cancer: Associated gene functions indicate the potential acquisition of enhanced cell plasticity and motility and provide a rationale to investigating mechanisms resulting in acquired chemoresistance, particularly for luminal A breast cancer, but potentially with general implication for p53 wild type tumors of different tissue types, and for overcoming such resistance by targeting NFκB.